Journal
CRYSTAL GROWTH & DESIGN
Volume 18, Issue 8, Pages 4416-4419Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.cgd.8b00375
Keywords
-
Funding
- National Science Foundation [DMR-1708673]
- CONACYT-COVEICYDET
- University of Iowa Graduate College
Ask authors/readers for more resources
We report the discovery of three polymorphs of the very recently FDA-approved boron-containing active pharmaceutical ingredient, Crisaborole. Crisaborole displays polymorphism based on the syn (Form I) and anti (Form II) conformations of the hydroxyl group of the oxaborole ring as shown by single-crystal X-ray analysis. Forms I and II were discovered based on the availability from two different commercial suppliers, while Form III was obtained upon heating of Form I or II. A cocrystal based on 4,4'-bipyridine was also obtained.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available